GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Oyj (OTCPK:ORINY) » Definitions » Forward PE Ratio

Orion Oyj (Orion Oyj) Forward PE Ratio : 0.00 (As of May. 17, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Orion Oyj Forward PE Ratio?

Orion Oyj's Forward PE Ratio for today is 0.00.

Orion Oyj's PE Ratio without NRI for today is 24.01.

Orion Oyj's PE Ratio for today is 24.01.


Orion Oyj Forward PE Ratio Historical Data

The historical data trend for Orion Oyj's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Oyj Forward PE Ratio Chart

Orion Oyj Annual Data
Trend 2018-12 2019-12 2020-12 2021-12 2022-12 2023-12 2024-01
Forward PE Ratio
22.27 27.10 25.51 25.06 26.18 24.57 27.17

Orion Oyj Quarterly Data
2018-03 2018-06 2018-09 2018-12 2019-03 2019-06 2019-09 2019-12 2020-03 2020-06 2020-09 2020-12 2021-03 2021-06 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03 2023-06 2023-09 2023-12
Forward PE Ratio 15.97 19.38 20.37 22.27 24.04 20.92 24.88 27.10 25.32 26.46 31.35 25.51 29.15 28.65 25.06 25.19 27.78 20.20 26.18 32.26 29.24 23.81 24.57

Competitive Comparison of Orion Oyj's Forward PE Ratio

For the Drug Manufacturers - General subindustry, Orion Oyj's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Oyj's Forward PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orion Oyj's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Orion Oyj's Forward PE Ratio falls into.



Orion Oyj Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Orion Oyj  (OTCPK:ORINY) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Orion Oyj Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Orion Oyj's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Oyj (Orion Oyj) Business Description

Address
Orionintie 1, P.O. Box 65, Espoo, FIN, FI-02200
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company primarily focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries and North America.

Orion Oyj (Orion Oyj) Headlines

From GuruFocus

Q4 2023 Orion Oyj Earnings Call Transcript

By GuruFocus Research 02-14-2024